Key facts
- It has raised $4.1M; the latest was Seed Round ($4.1M) in Jan 2026.
- Notable investors include Caelestinus, Acibadem University Tekmer, InterSystems Ventures, Kickstart Innovation.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Traverse Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Traverse Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Traverse Health
Developer of federated healthcare data infrastructure and analytics software designed for real-world evidence generation. The company's platform connects hospitals through on-premise or cloud nodes, harmonizes electronic health records to standard data models, applies de-identification and governance, and provides cohort discovery, feasibility assessments, and analytics across sites without centralizing patient-level data, enabling pharmaceutical sponsors, medical device companies, hospitals, and public health agencies to conduct research with a focus on underrepresented patient populations in emerging markets.
- Sector
- Healthcare
- HQ
- Oude Meer, Netherlands
- Founded
- 2022
- Employees
- 10
- Website
- traverse.health/
- Ownership
- Privately Held (backing)
Traverse Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Traverse Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Traverse Health in its N-PORT filings yet. We sweep new filings monthly.